Categories
CDE Diabetes

Practice Exam: Diabetes and Pregnancy (Chapter 36)

Pregnancy acts as a metabolic stress test, and hyperglycemia during this critical period carries significant risks for both the mother and the developing fetus. The 2018 Clinical Practice Guidelines provide rigorous standards for pre-conception counseling, screening protocols, and tight glycemic targets to ensure the best possible start for the next generation.

This practice exam tests your ability to navigate the specific diagnostic algorithms for Gestational Diabetes Mellitus (GDM), manage complex insulin regimens during changing physiology, and ensure appropriate postpartum follow-up.

Key Concepts Covered in This Exam:

  • Pre-conception Care: Mastering the checklist for women with pre-existing diabetes, including the recommendation for 1 mg of folic acid daily and achieving an A1C target of 7.0% (optimally 6.5%) prior to conception.

  • Screening & Diagnosis: Differentiating between the “Preferred” Two-Step Approach (50g screening followed by 75g diagnostic OGTT) and the “Alternative” One-Step Approach.

  • Glycemic Targets: Memorizing the strict targets during pregnancy: Fasting/preprandial <5.3 mmol/L, 1-hour postprandial <7.8 mmol/L, and 2-hour postprandial <6.7 mmol/L.

  • Pharmacotherapy: Identifying insulin as the first-line therapy for GDM and understanding the specific limitations and placental transfer of oral agents like metformin and glyburide.

  • Postpartum Follow-up: Recognizing that women with GDM are at high risk for developing Type 2 diabetes and require screening with a 75g OGTT between 6 weeks and 6 months postpartum.

1. Case: A woman with type 1 diabetes on CSII (insulin pump) is in active labour. She and her partner are comfortable managing her pump. What is the most appropriate recommendation regarding insulin delivery during labour?

2. Case: A pregnant woman with type 1 diabetes at 28 weeks gestation has a sudden 20% decrease in insulin requirements over 2 weeks. What is the most appropriate clinical consideration?

3. Case: A woman with type 1 diabetes at 8 weeks gestation has experienced two severe hypoglycemic episodes. Which factors are predictive of severe hypoglycemia during pregnancy?

4. At what gestational age should ASA 81 mg daily be started in women with pre-existing diabetes to reduce the risk of preeclampsia?

5. Case: A woman with pre-existing diabetes at 34 weeks gestation requires betamethasone for fetal lung maturation. According to the recommended protocol, how should insulin doses be adjusted on Days 2 and 3 after the first dose?

6. Case: A 28-year-old woman with a BMI of 23 kg/m² is diagnosed with diabetes at 26 weeks gestation. She has no risk factors for GDM, negative autoantibodies, and her mother and maternal grandmother were both diagnosed with diabetes before age 30. What is the most appropriate clinical reasoning?

7. Case: A 38-year-old woman with a BMI of 34 kg/m², prior GDM, and a mother with type 2 diabetes is at 10 weeks gestation. What early screening approach is recommended?

8. A woman at 25 weeks gestation has a 50g glucose challenge test result of 8.5 mmol/L. What is the next appropriate step?

9. According to the preferred screening approach for gestational diabetes, what glucose challenge test (GCT) value is diagnostic for GDM without requiring further testing?

10. At what gestational age should all pregnant women without known pre-existing diabetes be screened for gestational diabetes?

11. What is the most common form of monogenic diabetes identified during pregnancy in Canada?

12. Case: A woman with GDM at 36 weeks gestation asks about timing of delivery. Her blood glucose is well-controlled on diet alone with no comorbidities. What is the recommended timing of delivery?

13. Case: A woman with prior GDM has a postpartum 75g OGTT showing impaired glucose tolerance. She asks about strategies to prevent progression to type 2 diabetes. Based on evidence, what interventions have demonstrated benefit in this population?

14. Why is glyburide NOT recommended as first- or second-line treatment for GDM according to current guidelines?

15. Case: A woman with type 1 diabetes asks about retinopathy monitoring during pregnancy. What ophthalmological assessment schedule is recommended?

16. Using the preferred 2-step screening approach, what fasting plasma glucose value on a 75g OGTT would diagnose gestational diabetes?

17. Case: A 32-year-old woman with type 1 diabetes is planning pregnancy. Her current A1C is 8.2%. She is taking lisinopril for mild hypertension and atorvastatin for dyslipidemia. What is the most appropriate preconception recommendation?

18. Case: A woman with GDM has been on nutritional therapy for 2 weeks. Her fasting blood glucose levels remain at 5.8-6.2 mmol/L and 1-hour postprandial values are 8.5-9.0 mmol/L. What is the most appropriate next step?

19. According to the guidelines, what is the recurrence rate of gestational diabetes in subsequent pregnancies?

20. A clinical team is debating the preferred vs. alternative GDM screening approaches. Which statement best reflects the key difference between these approaches?

21. What is the fasting plasma glucose target for pregnant women with gestational diabetes?

22. What folic acid supplementation dose is recommended for women with pre-existing diabetes planning pregnancy?

23. A healthcare team is reviewing evidence on GDM prevention. Which intervention has demonstrated a significant 60% reduction in GDM development in one randomized controlled trial?

24. A woman with type 1 diabetes has just delivered. How should her insulin doses be adjusted in the immediate postpartum period?

25. A diabetes educator is developing patient education materials about breastfeeding for women with type 1 diabetes. Which statement about breastfeeding and diabetes medication is most accurate?

26. What percentage of women who conceive on metformin will ultimately require add-on insulin therapy to achieve adequate glycemic control during pregnancy?

27. What is the first-line therapy for gestational diabetes according to Diabetes Canada guidelines?

28. What is the target A1C recommended by Diabetes Canada for women with pre-existing diabetes during pregnancy, if it can be safely achieved?

29. Case: A woman with type 1 diabetes is considering pregnancy but has an eGFR of 55 mL/min/1.73 m² and significant proteinuria. Based on current evidence, what counselling about pregnancy and renal function is most accurate?

30. What minimum duration of breastfeeding is recommended for women with gestational diabetes to help prevent childhood obesity and diabetes?

31. Case: A woman with pre-existing diabetes has severe nonproliferative retinopathy. She is planning pregnancy. What preconception intervention reduces the risk of visual impairment during pregnancy?

32. What is the incidence of hypertension complicating pregnancy in women with type 1 and type 2 diabetes?

33. A diabetes educator is counselling a woman with newly diagnosed GDM about evidence-based dietary approaches. Based on current meta-analyses, which dietary intervention has demonstrated reduced insulin use and lower newborn weight without increasing SGA?

34. Which rapid-acting insulin analogue has been studied in a randomized trial of 322 pregnant women with type 1 diabetes and shown to reduce episodes of major hypoglycemia?

35. What is the target blood glucose range during labour and delivery in women with diabetes to minimize neonatal hypoglycemia?

36. After 16 years of follow-up, what percentage of women with prior gestational diabetes will develop type 2 diabetes?

37. What is the recommended postpartum screening test and timeframe for women who had gestational diabetes?

38. Case: A woman with type 2 diabetes becomes pregnant while taking glyburide and metformin. What is the most appropriate management of her diabetes medications?